title: What is the best method of prevention of therapeutic failures in CNS in high risk retinoblastoma?
authors.forename: J
authors.initials: J
authors.lastname: Grześkowiak-Melanowska
authors.forename: S
authors.initials: S
authors.lastname: Skoczeń
authors.forename: J
authors.initials: J
authors.lastname: Armata
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000517:prevention & control / Q000556:secondary*; D002675:Child, Preschool; D002699:Chlorambucil / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009918:Orbital Neoplasms / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage; D012175:Retinoblastoma / Q000188:drug therapy* / Q000556:secondary; D012307:Risk Factors; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D002699:Chlorambucil; D014750:Vincristine; D005047:Etoposide; D011239:Prednisolone